Anhedonia Clinical Trials
3 recruiting trials for Anhedonia. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Anhedonia clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Riccardo Guglielmo (1), San Francisco Veterans Affairs Medical Center (1), University of Texas at Austin (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Esketamine (Intranasal Spray) (drug, 1 trial), followed by cross-sectional MRI and EEG assessments (NO INTERVENTION), Cognitive Processing Therapy.
Track Anhedonia trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
This observational study investigates the use of Esketamine Intranasal Spray in patients with Treatment-Resistant Depression in Real-World Settings. The study aims to evaluate the...
Reward Processing and Depressive Subtypes: Identifying Neural Biotypes
Deficits in motivation and pleasure are common in depression, and thought to be caused by alterations in the ways in which the brain anticipates, evaluates, and adaptively uses...
Psychotherapy Effects on Reward Processing in PTSD
The purpose of this study is to identify how trauma-focused psychotherapy changes the function of brain circuitry in posttraumatic stress disorder (PTSD) and how this mediates...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Anhedonia, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Anhedonia, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Anhedonia, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.